UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~Securities~~Date ~~Exchange~~of ~~Act~~report (Date of ~~1934~~earliest event reported): March 23, 2026

Date of report (Date of earliest event reported): February 23, 2026

Lord Abbett Private Credit Fund S

(Exact name of Registrant as Specified in Its Charter)

DELAWARE		814-01843		99-5126353
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

30 Hudson Street Jersey City, New Jersey		07302
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (888) 522-2388

N/A

(Former Name or Former Address, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.02. Unregistered Sales of Equity Securities.

As of ~~February~~March 2, 2026, Lord Abbett Private Credit Fund S ("“we"”, the "“Company"” or the "“Fund"”), issued and sold approximately ~~760~~1,~~191~~149,666 of the Company’s common shares of beneficial interest (the “Common Shares”) for an aggregate offering price of approximately $1928.1 6 million, reflecting a purchase price of $2524.0787 per Common Share (with the final number of Common Shares being determined on ~~February~~March 23, 2026).

The offer and sale of Common Shares was made pursuant to subscription agreements entered into by the Company and its shareholders. The issuance of the Common Shares is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Company relied, in part, upon representations from the shareholders in the subscription agreements that each shareholder was an accredited investor as defined in Regulation D under the Securities Act.

Item 7.01. Regulation FD Disclosure.

Company'’s Portfolio:

As of ~~January~~February 3128, 2026, the Company had made ~~loans~~ loans to 4344 portfolio companies, held an equity position in one portfolio company, and held one investment in a joint venture, with an aggregate loan commitment amount of approximately $~~390~~384 million and par value of approximately $~~313~~296 million,. The portfolio consists of 9493% senior secured debt investments and 67% investment in a joint venture, based on par value or in the case of investments in a joint venture, cost. As of ~~January~~February 3128, 2026, 100% of the debt investments, based on par value, in the Company'’s portfolio were at floating rates. As of ~~January 31~~February 28, 2026, 99% of the Company’s total loan commitments were in private senior secured loans. The following table presents information concerning portfolio companies to which the Company has made loans.

Portfolio Company Metrics(1):
Median 12-month EBITDA:	$7578 million(2)
Weighted average net leverage:	4.5x(2)(3)
Weighted average loan to value:	4041%(2)(4)
Weighted average interest coverage:	2.4x(2)(5)
Weighted average yield on debt investments, at cost:	9.2%(6)

(1) Amounts were derived from the most recently available financial statements provided by portfolio companies which have not been independently verified by us and may reflect a normalized or adjusted amount. Such amounts have not been independently estimated by us, and accordingly, we take no responsibility for such numbers and make no representation or warranty in respect of this information.

(1)	Amounts were derived from the most recently available financial statements provided by portfolio companies which have not been independently verified by us and may reflect a normalized or adjusted amount. Such amounts have not been independently estimated by us, and accordingly, we take no responsibility for such numbers and make no representation or warranty in respect of this information.

(2)	Metrics exclude one liquid loan. Metrics also exclude one recurring revenue investment, which are investments in portfolio companies in which the Company lends based on a multiple of recurring revenue generated by the portfolio company and not based on a multiple of EBITDA. Weighted average metrics are calculated as a percentage of funded par value of debt investments.

(3)	Net leverage is the ratio of total senior debt minus cash divided by EBITDA and taking into account leverage through the tranche to which the Company is a lender.

(4)	Calculated using total senior debt minus cash divided by total enterprise value estimated by the private equity sponsor or market comparables and taking into account leverage through the tranche to which the Company is a lender.

(2) Metrics exclude one liquid loan. Metrics also exclude one recurring revenue investment, which are investments in portfolio companies in which the Company lends based on a multiple of recurring revenue generated by the portfolio company and not based on a multiple of EBITDA. Weighted average metrics are calculated as a percentage of funded par value of debt investments.

(5)	Interest coverage for a particular portfolio company is calculated by taking EBITDA and dividing by annualized latest reported interest expense.

(6)	Computed as (a) the annual stated spread, plus reference rate, as applicable, plus the annual accretion of discounts, plus the annual unused fees, as applicable on debt securities divided by (b) total debt investments at cost included in such securities. Actual yields earned over the life of each investment could differ materially from the yields presented herein.

~~(3)~~The ~~Net~~table ~~leverage~~below isshows the ~~ratio~~Company’s ofloan ~~total~~investment activity ~~senior~~during ~~debt~~the ~~minus~~period ~~cash~~February ~~divided~~1, by2026, ~~EBITDA~~through ~~and~~February ~~taking~~28, ~~into~~2026. ~~account~~Amounts ~~leverage~~shown ~~through~~for ~~the~~commitment ~~tranche~~amount toand ~~which~~par ~~the~~value ~~Company~~are as isof aFebruary ~~lender.~~28, 2026:

(4) Calculated using total senior debt minus cash divided by total enterprise value estimated by the private equity sponsor or market comparables and taking into account leverage through the tranche to which the Company is a lender.

Issuer	Commitment Amount ($ in millions)	Par Amount ($ in millions)
Association Resource Group, LLC	$16.9	$8.3
Frozen Garlic Bread Holdings Inc	$17.0	$12.9
MGS Mfg. Group, Inc.	$10.1	$6.8
Total	$44.0	$28.0

~~(5)~~The ~~Interest~~table ~~coverage~~below ~~for~~describes ainvestments ~~particular~~by ~~portfolio~~industry composition ~~company~~based ison ~~calculated~~par byvalue ~~taking~~or, ~~EBITDA~~in ~~and~~the ~~dividing~~case byof ~~annualized~~equity ~~latest~~investments, ~~reported~~cost ~~interest~~as ~~expense.~~of February 28, 2026:

(6) Computed as (a) the annual stated spread, plus reference rate, as applicable, plus the annual accretion of discounts, plus the annual unused fees, as applicable on debt securities divided by (b) total debt investments at cost included in such securities. Actual yields earned over the life of each investment could differ materially from the yields presented herein.

Industry	Par or Cost ($ in millions)	% of Total
Health Care Providers & Services	$48.0	16.2%
Commercial Services & Supplies	43.1	14.6
Air Freight & Logistics	39.5	13.3
Software	30.3	10.2
IT Services	15.1	5.1
Health Care Equipment & Supplies	14.4	4.9
Food Products	12.9	4.4
Telecommunication Services	12.8	4.3
Textiles, Apparel & Luxury Goods	11.4	3.8
Aerospace & Defense	11.3	3.8
Others	57.4	19.4
Total	$296.2	100.0%

The table below shows the Company's loan investment activity during the period January 1, 2026, through January 31, 2026. Amounts shown for commitment amount and par value are as of January 31, 2026:

Issuer	Commitment Amount ($ in millions)		Par Amount ($ in millions)
Colorescience Inc		$1.9		$1.6
Forge Borrower, LLC		$4.8		$1.8
Leg Purchaser Inc		$3.8		$3.5
Maverick Power, LLC		$3.1		$3.1
Total		$13.6		$10.0

Item 8.01. Other Events.

Distribution:

On ~~February 24~~March 23, 2026, the Company declared a distribution of approximately $0.19 per share to shareholders of record as of ~~February~~March 2831, 2026 to be paid on or about ~~March~~April 2629, 2026.

Net Asset Value

As of ~~January~~February 3128, 2026, the Company’s ~~aggregate~~ aggregate net asset value (“NAV”) was approximately $~~140~~158 million. The NAV per share of Common Shares as of ~~January 31~~February 28, 2026, as determined in accordance with the Company’s valuation policy, was $2524.0787 per Common Share.

Final results related to all of the above information and other information may differ materially as a result of the completion of the Company’s financial closing procedures, which will occur between the date hereof and the completion of the financial statements and the filing of the Company’s quarterly report on Form 10-Q for the quarter ending March 31, 2026.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		LORD ABBETT PRIVATE CREDIT FUND S		~~LORD ABBETT PRIVATE CREDIT FUND S~~
Date: February 27, 2026			By:	/s/ Salvatore Dona
Date: March 27, 2026	By:	/s/ Salvatore Dona
	Name:	Salvatore Dona	~~Name:~~	~~Salvatore Dona~~
	Title:	Chief Financial Officer	~~Title:~~	~~Chief Financial Officer~~

Filing Compare · Lord Abbett Private Credit Fund S